The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...

Patients with celiac disease have double the incidence rate of chronic liver disease compared with those without this ...

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...

The researchers found that having ever used oral contraception reduced odds of ovarian cancer by 26% (odds ratio [OR], 0.74; 95% CI, 0.66-0.84). Further, those who stopped using oral contraception at ...

Johns Hopkins University School of Medicine researchers have discovered a dual regulatory mechanism safeguarding ...

Researchers from Georgia Southern University's Jiann-Ping Hsu College of Public Health have discovered a positive trend in ...

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGSNet product sales of FILSPARI ...

Solid Biosciences (SLDB) announced initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

Tremtelectogene empogeditemcel (trem-cel) may make gemtuzumab ozogamicin maintenance safer for patients with high-risk acute myeloid leukemia (AML), according to results of a phase 1/2 trial presented ...